Items where Author is "Hadjati, J."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 5.

Article

Mirzaei, H. and Sahebkar, A. and Avan, A. and Jaafari, M. R. and Salehi, R. and Salehi, H. and Baharvand, H. and Rezaei, A. and Hadjati, J. and Pawelek, J. M. and Mirzaei, H. R. (2016) Application of mesenchymal stem cells in melanoma: A potential therapeutic strategy for delivery of targeted agents. Current Medicinal Chemistry, 23 (5). pp. 455-463.

Salarinia, R. and Sahebkar, A. and Peyvandi, M. and Mirzaei, H. R. and Jaafari, M. R. and Riahi, M. M. and Ebrahimnejad, H. and Nahand, J. S. and Hadjati, J. and Asrami, M. O. and Fadaei, S. and Salehi, R. and Mirzaei, H. (2016) Epi-drugs and epi-mirs: Moving beyond current cancer therapies. Current Cancer Drug Targets, 16 (9). pp. 773-788.

Salarinia, R. and Sahebkar, A. and Peyvandi, M. and Mirzaei, H. R. and Jaafari, M. R. and Riahi, M. M. and Ebrahimnejad, H. and Nahand, J. S. and Hadjati, J. and Asrami, M. O. and Fadaei, S. and Salehi, R. and Mirzaei, H. (2016) Epi-drugs and epi-mirs: Moving beyond current cancer therapies. Current Cancer Drug Targets, 16 (9). pp. 773-788.

Salarinia, R. and Sahebkar, A. and Peyvandi, M. and Mirzaei, H. R. and Jaafari, M. R. and Riahi, M. M. and Ebrahimnejad, H. and Nahand, J. S. and Hadjati, J. and Asrami, M. O. and Fadaei, S. and Salehi, R. and Mirzaei, H. (2016) Epi-drugs and epi-mirs: Moving beyond current cancer therapies. Current Cancer Drug Targets, 16 (9). pp. 773-788.

Mirzaei, H. and Sahebkar, A. and Jaafari, M. R. and Hadjati, J. and Javanmard, S. H. and Mirzaei, H. R. and Salehi, R. (2016) PiggyBac as a novel vector in cancer gene therapy: Current perspective. Cancer Gene Therapy, 23 (2-3). pp. 45-47.

This list was generated on Sun Sep 27 23:13:04 2020 EDT.